{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:55:05Z","timestamp":1787313305904,"version":"build-2736575974"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Scientific Research Project of Hunan Provincial Health Commission","award":["NO.W20243154"],"award-info":[{"award-number":["NO.W20243154"]}]},{"DOI":"10.13039\/501100004761","name":"Hunan Province Natural Science Foundation of China","doi-asserted-by":"crossref","award":["NO.2022JJ70085"],"award-info":[{"award-number":["NO.2022JJ70085"]}],"id":[{"id":"10.13039\/501100004761","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004761","name":"Hunan Province Natural Science Foundation of China","doi-asserted-by":"crossref","award":["NO.2023JJ50219"],"award-info":[{"award-number":["NO.2023JJ50219"]}],"id":[{"id":"10.13039\/501100004761","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-04323-z","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T12:24:48Z","timestamp":1768393488000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Indigestible carbohydrates suppress colorectal cancer through IRF6\/TRAF3\/IFN\u03b1 pathway"],"prefix":"10.1007","volume":"17","author":[{"given":"Lin","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linhui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binbin","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingfei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dajun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunzhu","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,14]]},"reference":[{"issue":"2","key":"4323_CR1","first-page":"104","volume":"64","author":"R Siegel","year":"2014","unstructured":"Siegel R, Desantis C, Jemal A. Colorectal cancer statistics, 2014. CA Cancer J Clin. 2014;64(2):104\u201317.","journal-title":"CA Cancer J Clin"},{"key":"4323_CR2","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.cancergen.2024.06.002","volume":"286\u2013287","author":"D Sonkin","year":"2024","unstructured":"Sonkin D, Thomas A, Teicher BA. Cancer treatments: Past, present, and future. Cancer Genet. 2024;286\u2013287:18\u201324.","journal-title":"Cancer Genet"},{"issue":"4","key":"4323_CR3","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1136\/gutjnl-2015-310912","volume":"66","author":"M Arnold","year":"2017","unstructured":"Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global patterns and trends in colorectal cancer incidence and mortality. Gut. 2017;66(4):683\u201391.","journal-title":"Gut"},{"issue":"2","key":"4323_CR4","first-page":"246","volume":"18","author":"E Pishgar","year":"2025","unstructured":"Pishgar E, Mahdavi H. Helicobacter pylori infection in patients with colorectal adenocarcinoma and its association with tumor grade and location: a cross-sectional study. Gastroenterol Hepatol Bed Bench. 2025;18(2):246\u201351.","journal-title":"Gastroenterol Hepatol Bed Bench"},{"key":"4323_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.117428","volume":"320","author":"L Ou","year":"2024","unstructured":"Ou L, Liu HR, Shi XY, Peng C, Zou YJ, Jia JW, et al. Terminalia chebula Retz. aqueous extract inhibits the Helicobacter pylori-induced inflammatory response by regulating the inflammasome signaling and ER-stress pathway. J Ethnopharmacol. 2024;320:117428.","journal-title":"J Ethnopharmacol"},{"issue":"5","key":"4323_CR6","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.3390\/molecules29051161","volume":"29","author":"L Ou","year":"2024","unstructured":"Ou L, Zhu Z, Hao Y, Li Q, Liu H, Chen Q, Peng C, Zhang C, Zou Y, Jia J, Li H, Wang Y, Su B, Lai Y, Chen M, Chen H, Feng Z, Zhang G, Yao M. 1,3,6-Trigalloylglucose: A Novel Potent Anti-Helicobacter pylori Adhesion Agent Derived from Aqueous Extracts of Terminalia chebula Retz. Mol. 2024;29(5):1161.","journal-title":"Mol"},{"key":"4323_CR7","doi-asserted-by":"publisher","first-page":"1416794","DOI":"10.3389\/fmicb.2024.1416794","volume":"15","author":"L Ou","year":"2024","unstructured":"Ou L, Hao Y, Liu H, Zhu Z, Li Q, Chen Q, et al. Chebulinic acid isolated from aqueous extracts of terminalia chebula Retz inhibits Helicobacter pylori infection by potential binding to Cag A protein and regulating adhesion. Front Microbiol. 2024;15:1416794.","journal-title":"Front Microbiol"},{"issue":"1","key":"4323_CR8","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1186\/s12906-025-04989-6","volume":"25","author":"L Ou","year":"2025","unstructured":"Ou L, Chen H, Hao Y, Liu H, Zhu Z, Li Q, et al. In vitro antibacterial activity of neochebulinic acid from aqueous extract of terminalia chebula Retz against Helicobacter pylori. BMC Complement Med Ther. 2025;25(1):287.","journal-title":"BMC Complement Med Ther"},{"issue":"3","key":"4323_CR9","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1097\/JS9.0000000000002229","volume":"111","author":"Q Yuan","year":"2025","unstructured":"Yuan Q, Liu J, Wang X, Du C, Zhang Y, Lin L, Wang C, Hong Z. Deciphering the impact of dietary habits and behavioral patterns on colorectal cancer. Int J Surg (London England). 2025;111(3):2603\u201312.","journal-title":"Int J Surg (London England)"},{"issue":"9","key":"4323_CR10","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1002\/mc.22666","volume":"56","author":"FC Malcomson","year":"2017","unstructured":"Malcomson FC, Willis ND, McCallum I, Xie L, Lagerwaard B, Kelly S, et al. Non-digestible carbohydrates supplementation increases miR-32 expression in the healthy human colorectal epithelium: a randomized controlled trial. Mol Carcinog. 2017;56(9):2104\u201311.","journal-title":"Mol Carcinog"},{"issue":"6","key":"4323_CR11","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1053\/j.gastro.2010.01.054","volume":"138","author":"KW Jasperson","year":"2010","unstructured":"Jasperson KW, Tuohy TM, Neklason DW, Burt RW. Hereditary and familial colon cancer. Gastroenterology. 2010;138(6):2044\u201358.","journal-title":"Gastroenterology"},{"issue":"3","key":"4323_CR12","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.maturitas.2014.12.017","volume":"80","author":"R Baena","year":"2015","unstructured":"Baena R, Salinas P. Diet and colorectal cancer. Maturitas. 2015;80(3):258\u201364.","journal-title":"Maturitas"},{"issue":"11","key":"4323_CR13","first-page":"1935","volume":"24","author":"E Vogtmann","year":"2013","unstructured":"Vogtmann E, Xiang YB, Li HL, Levitan EB, Yang G, Waterbor JW, Gao J, Cai H, Xie L, Wu QJ, Zhang B, Gao YT, Zheng W, Shu XO. Fruit and vegetable intake and the risk of colorectal cancer: results from the Shanghai men\u2019s health study. Cancer Causes Control. 2013;24(11):1935\u201345.","journal-title":"Cancer Causes Control"},{"issue":"3","key":"4323_CR14","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1017\/S002966511500004X","volume":"74","author":"FC Malcomson","year":"2015","unstructured":"Malcomson FC, Willis ND, Mathers JC. Is resistant starch protective against colorectal cancer via modulation of the WNT signalling pathway? Proc Nutr Soc. 2015;74(3):282\u201391.","journal-title":"Proc Nutr Soc"},{"key":"4323_CR15","doi-asserted-by":"publisher","first-page":"5930","DOI":"10.1038\/ncomms6930","volume":"6","author":"J Jin","year":"2015","unstructured":"Jin J, Xiao Y, Hu H, Zou Q, Li Y, Gao Y, Ge W, Cheng X, Sun SC. Proinflammatory TLR signalling is regulated by a TRAF2-dependent proteolysis mechanism in macrophages. Nat Commun. 2015;6:5930.","journal-title":"Nat Commun"},{"key":"4323_CR16","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13045-014-0056-6","volume":"7","author":"SK Edwards","year":"2014","unstructured":"Edwards SK, Baron J, Moore CR, Liu Y, Perlman DH, Hart RP, Xie P. Mutated in colorectal cancer (MCC) is a novel oncogene in B lymphocytes. J Hematol Oncol. 2014;7:56.","journal-title":"J Hematol Oncol"},{"key":"4323_CR17","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.bcp.2018.05.017","volume":"154","author":"G Zong","year":"2018","unstructured":"Zong G, Zhu Y, Zhang Y, Wang Y, Bai H, Yang Q, Ben J, Zhang H, Li X, Zhu X, Chen Q. SR-A1 suppresses colon inflammation and tumorigenesis through negative regulation of NF-kappaB signaling. Biochem Pharmacol. 2018;154:335\u201343.","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"4323_CR18","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/j.1399-0004.2010.01375.x","volume":"78","author":"S Malik","year":"2010","unstructured":"Malik S, Kakar N, Hasnain S, Ahmad J, Wilcox ER, Naz S. Epidemiology of Van der woude syndrome from mutational analyses in affected patients from Pakistan. Clin Genet. 2010;78(3):247\u201356.","journal-title":"Clin Genet"},{"issue":"Irf6","key":"4323_CR19","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1038\/ng1903","volume":"6","author":"CR Ingraham","year":"2006","unstructured":"Ingraham CR, Kinoshita A, Kondo S, Yang B, Sajan S, Trout KJ, Malik MI, Dunnwald M, Goudy SL, Lovett M, Murray JC, Schutte BC. Abnormal skin, limb and craniofacial morphogenesis in mice deficient for interferon regulatory factor. Nat Genet. 2006;6(Irf6):1335\u201340.","journal-title":"Nat Genet"},{"issue":"9","key":"4323_CR20","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1002\/mc.23752","volume":"63","author":"X Tong","year":"2024","unstructured":"Tong X, Li C, Ma L, Wu D, Liu Y, Zhao L, Wang M. Potentially functional genetic variants in interferon regulatory factor family genes are associated with colorectal cancer survival. Mol Carcinog. 2024;63(9):1669\u201381.","journal-title":"Mol Carcinog"},{"key":"4323_CR21","doi-asserted-by":"publisher","first-page":"5557","DOI":"10.2147\/CMAR.S203060","volume":"11","author":"HF Xu","year":"2019","unstructured":"Xu HF, Huang TJ, Yang Q, Xu L, Lin F, Lang YH, Hu H, Peng LX, Meng DF, Xie YJ, Tan L, Qian CN, Huang BJ. Candidate tumor suppressor gene IRF6 is involved in human breast cancer pathogenesis via modulating PI3K-regulatory subunit PIK3R2 expression. Cancer Manag Res. 2019;11:5557\u201372.","journal-title":"Cancer Manag Res"},{"issue":"4","key":"4323_CR22","doi-asserted-by":"publisher","first-page":"10504","DOI":"10.1080\/21655979.2022.2062103","volume":"13","author":"L Tan","year":"2022","unstructured":"Tan L, Qu W, Wu D, Liu M, Ai Q, Hu H, Wang Q, Chen W, Zhou H. The interferon regulatory factor 6 promotes cisplatin sensitivity in colorectal cancer. Bioengineered. 2022;13(4):10504\u201317.","journal-title":"Bioengineered"},{"key":"4323_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.115052","volume":"161","author":"Y Qin","year":"2025","unstructured":"Qin Y, Liu L, Luo S, He H, Sun X, Zhang Q, et al. Sodium butyrate induces colorectal cancer cell apoptosis via the MCU\/Drp1 pathway. Int Immunopharmacol. 2025;161:115052.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"4323_CR24","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-025-05782-x","volume":"82","author":"Q Zhou","year":"2025","unstructured":"Zhou Q, Li Y, Li X, Zhang S, Wang Y, Li Z, et al. Pleckstrin-2 promotes the progression of colorectal cancer via YTHDF2-mediated TYMS mRNA stability. Cell Mol Life Sci. 2025;82(1):284.","journal-title":"Cell Mol Life Sci"},{"issue":"2","key":"4323_CR25","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott O, Olson A. AutoDock vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010;31(2):455\u201361.","journal-title":"J Comput Chem"},{"issue":"2","key":"4323_CR26","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1097\/MOG.0b013e32835b9aa3","volume":"29","author":"JA Higgins","year":"2013","unstructured":"Higgins JA, Brown IL. Resistant starch: a promising dietary agent for the prevention\/treatment of inflammatory bowel disease and bowel cancer. Curr Opin Gastroenterol. 2013;29(2):190\u20134.","journal-title":"Curr Opin Gastroenterol"},{"issue":"5","key":"4323_CR27","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1017\/S0007114512001948","volume":"108","author":"KY Fung","year":"2012","unstructured":"Fung KY, Cosgrove L, Lockett T, Head R, Topping DL. A review of the potential mechanisms for the lowering of colorectal oncogenesis by butyrate. Br J Nutr. 2012;108(5):820\u201331.","journal-title":"Br J Nutr"},{"key":"4323_CR28","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/1083952","volume":"2019","author":"Z Zeaiter","year":"2019","unstructured":"Zeaiter Z, Regonesi ME, Cavini S, Labra M, Sello G, Di Gennaro P. Extraction and characterization of inulin-type fructans from artichoke wastes and their effect on the growth of intestinal bacteria associated with health. Biomed Res Int. 2019;2019:1083952.","journal-title":"Biomed Res Int"},{"issue":"3\u20134","key":"4323_CR29","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/0169-328X(92)90243-5","volume":"16","author":"D Baines","year":"1992","unstructured":"Baines D, Mallon BS, Love S. Effects of sodium butyrate on the expression of sodium channels by neuronal cell lines derived from the rat CNS. Brain research Molecular brain research. 1992;16(3\u20134):330\u20138.","journal-title":"Brain research. Molecular brain research"},{"key":"4323_CR30","doi-asserted-by":"publisher","DOI":"10.17352\/2581-5407.000032","author":"H Liu","year":"2020","unstructured":"Liu H. Nav channels in cancers: nonclassical roles. Global J Cancer Ther. 2020;28\u201332.","journal-title":"Global J Cancer Ther"},{"issue":"2","key":"4323_CR31","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12785","volume":"26","author":"Y Huang","year":"2021","unstructured":"Huang Y, Ding Y, Xu H, Shen C, Chen X, Li C. Effects of sodium butyrate supplementation on inflammation, gut microbiota, and short-chain fatty acids in Helicobacter pylori-infected mice. Helicobacter. 2021;26(2):e12785.","journal-title":"Helicobacter"},{"key":"4323_CR32","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-025-06883-2","author":"GG Tortelote","year":"2025","unstructured":"Tortelote GG. Therapeutic strategies for hypertension: exploring the role of microbiota-derived short-chain fatty acids in kidney physiology and development. Pediatr Nephrol. 2025. https:\/\/doi.org\/10.1007\/s00467-025-06883-2.","journal-title":"Pediatr Nephrol"},{"issue":"5","key":"4323_CR33","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1007\/s13238-018-0543-6","volume":"9","author":"J Yang","year":"2018","unstructured":"Yang J, Yu J. The association of diet, gut microbiota and colorectal cancer: what we eat may imply what we get. Protein Cell. 2018;9(5):474\u201387.","journal-title":"Protein Cell"},{"issue":"6","key":"4323_CR34","first-page":"3130","volume":"24","author":"XH Xiao","year":"2020","unstructured":"Xiao XH, He SY. ELF1 activated long non-coding RNA CASC2 inhibits cisplatin resistance of non-small cell lung cancer via the miR-18a\/IRF-2 signaling pathway. Eur Rev Med Pharmacol Sci. 2020;24(6):3130\u201342.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"4","key":"4323_CR35","first-page":"1255","volume":"10","author":"L Tan","year":"2020","unstructured":"Tan L, Yuan J, Zhu W, Tao K, Wang G, Gao J. Interferon regulatory factor-1 suppresses DNA damage response and reverses chemotherapy resistance by downregulating the expression of RAD51 in gastric cancer. Am J Cancer Res. 2020;10(4):1255\u201370.","journal-title":"Am J Cancer Res"},{"key":"4323_CR36","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31313","author":"GW Kim","year":"2020","unstructured":"Kim GW, Imam H, Khan M, Mir SA, Kim SJ, Yoon SK, et al. HBV-induced increased N6 methyladenosine modification of PTEN RNA affects innate immunity and contributes to HCC. Hepatology. 2020. https:\/\/doi.org\/10.1002\/hep.31313.","journal-title":"Hepatology"},{"key":"4323_CR37","doi-asserted-by":"publisher","DOI":"10.1097\/CAD.0000000000000852","author":"S Guo","year":"2019","unstructured":"Guo S, Zhu W, Yin Z, Xiao D, Zhang Q, Liu T, et al. Proanthocyanidins attenuate breast cancer-induced bone metastasis by inhibiting Irf-3\/c-jun activation. Anticancer Drugs. 2019. https:\/\/doi.org\/10.1097\/CAD.0000000000000852.","journal-title":"Anticancer Drugs"},{"issue":"4","key":"4323_CR38","doi-asserted-by":"publisher","first-page":"e1288330","DOI":"10.1080\/2162402X.2017.1288330","volume":"6","author":"VH Koelzer","year":"2017","unstructured":"Koelzer VH, Sokol L, Zahnd S, Christe L, Dawson H, Berger MD, Inderbitzin D, Zlobec I, Lugli A. Digital analysis and epigenetic regulation of the signature of rejection in colorectal cancer. Oncoimmunology. 2017;6(4):e1288330.","journal-title":"Oncoimmunology"},{"issue":"6","key":"4323_CR39","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1002\/ijc.30810","volume":"141","author":"S Okazaki","year":"2017","unstructured":"Okazaki S, Stintzing S, Sunakawa Y, Cao S, Zhang W, Yang D, Ning Y, Matsusaka S, Berger MD, Miyamoto Y, Suenaga M, Schirripa M, West JD, Gopez R, Akihito T, Ichikawa W, Heinemann V, DePaolo RW, Lenz HJ. Predictive value of TLR7 polymorphism for cetuximab-based chemotherapy in patients with metastatic colorectal cancer. Int J Cancer. 2017;141(6):1222\u201330.","journal-title":"Int J Cancer"},{"key":"4323_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/cells13171466","author":"H Muralidharan","year":"2024","unstructured":"Muralidharan H, Hansen T, Steinle A, Schumacher D, Stickeler E, Maurer J. Breast cancer stem cells Upregulate IRF6 in stromal fibroblasts to induce stromagenesis. Cells. 2024. https:\/\/doi.org\/10.3390\/cells13171466.","journal-title":"Cells"},{"issue":"1","key":"4323_CR41","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13048-024-01386-4","volume":"17","author":"S Hong","year":"2024","unstructured":"Hong S, Fu N, Sang S, Ma X, Sun F, Zhang X. Identification and validation of IRF6 related to ovarian cancer and biological function and prognostic value. J Ovarian Res. 2024;17(1):64.","journal-title":"J Ovarian Res"},{"issue":"8","key":"4323_CR42","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1093\/carcin\/bgae034","volume":"45","author":"P Zhou","year":"2024","unstructured":"Zhou P, Yang L, Ma X, Li Q. Sevoflurane inhibits lung cancer development by promoting FUS1 transcription via downregulating IRF6. Carcinogenesis. 2024;45(8):543\u201355.","journal-title":"Carcinogenesis"},{"key":"4323_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2019.105589","volume":"115","author":"N Sajjad","year":"2019","unstructured":"Sajjad N, Mir MM, Khan J, Rather IA, Bhat EA. Recognition of TRAIP with TRAFs: current understanding and associated diseases. Int J Biochem Cell Biol. 2019;115:105589.","journal-title":"Int J Biochem Cell Biol"},{"issue":"2","key":"4323_CR44","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ccr.2007.07.004","volume":"12","author":"CM Annunziata","year":"2007","unstructured":"Annunziata CM, Davis RE, Demchenko Y, Bellamy W, Gabrea A, Zhan F, et al. Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma. Cancer Cell. 2007;12(2):115\u201330.","journal-title":"Cancer Cell"},{"issue":"5","key":"4323_CR45","doi-asserted-by":"publisher","first-page":"729","DOI":"10.3324\/haematol.2010.030577","volume":"96","author":"J Du","year":"2011","unstructured":"Du J, Huo J, Shi J, Yuan Z, Zhang C, Fu W, et al. Polymorphisms of nuclear factor-kappaB family genes are associated with development of multiple myeloma and treatment outcome in patients receiving bortezomib-based regimens. Haematologica. 2011;96(5):729\u201337.","journal-title":"Haematologica"},{"issue":"3","key":"4323_CR46","first-page":"1251","volume":"21","author":"J Ding","year":"2020","unstructured":"Ding J, Qin D, Zhang Y, Li Q, Li Y, Li J. SMAC mimetic Birinapant inhibits hepatocellular carcinoma growth by activating the cIAP1\/TRAF3 signaling pathway. Mol Med Rep. 2020;21(3):1251\u20137.","journal-title":"Mol Med Rep"},{"issue":"1","key":"4323_CR47","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s40659-019-0245-4","volume":"52","author":"B Zhang","year":"2019","unstructured":"Zhang B, Shetti D, Fan C, Wei K. miR-29b-3p promotes progression of MDA-MB-231 triple-negative breast cancer cells through downregulating TRAF3. Biol Res. 2019;52(1):38.","journal-title":"Biol Res"},{"issue":"5","key":"4323_CR48","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.immuni.2012.03.012","volume":"36","author":"IC Allen","year":"2012","unstructured":"Allen IC, Wilson JE, Schneider M, Lich JD, Roberts RA, Arthur JC, Woodford RM, Davis BK, Uronis JM, Herfarth HH, Jobin C, Rogers AB, Ting JP. NLRP12 suppresses colon inflammation and tumorigenesis through the negative regulation of noncanonical NF-kappaB signaling. Immunity. 2012;36(5):742\u201354.","journal-title":"Immunity"},{"key":"4323_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/cells11203274","author":"K Ibraheem","year":"2022","unstructured":"Ibraheem K, Yhmed AMA, Nasef MM, Georgopoulos NT. TRAF3\/p38-JNK signalling crosstalk with intracellular-TRAIL\/Caspase-10-induced apoptosis accelerates ROS-driven cancer cell-specific death by CD40. Cells. 2022. https:\/\/doi.org\/10.3390\/cells11203274.","journal-title":"Cells"},{"key":"4323_CR50","doi-asserted-by":"publisher","first-page":"104930","DOI":"10.1016\/j.cellimm.2025.104930","volume":"409\u2013410","author":"L Du","year":"2025","unstructured":"Du L, Chen J, Du C, Chen J, Wang Z, Bao B, Zhonglin LV, Xing C, Liang M, Wang L, Xie S, Li Y, Wang Z, Li G, Zhang J, Han G. Tim-3 promotes viral infection by suppressing the USP25-TRAF3-IRF7 signaling pathway. Cell Immunol. 2025;409\u2013410:104930.","journal-title":"Cell Immunol"},{"issue":"2","key":"4323_CR51","first-page":"289","volume":"37","author":"H Liu","year":"2025","unstructured":"Liu H, Dilger J. Different strategies for cancer treatment: targeting cancer cells or their neighbors? Chin J Cancer Res = Chung-kuo Yen Cheng Yen Chiu. 2025;37(2):289\u201392.","journal-title":"Chin J Cancer Res = Chung-kuo Yen Cheng Yen Chiu"},{"issue":"20","key":"4323_CR52","doi-asserted-by":"publisher","first-page":"106443","DOI":"10.3748\/wjg.v31.i20.106443","volume":"31","author":"HR Liu","year":"2025","unstructured":"Liu HR. Harnessing traditional medicine and biomarker-driven approaches to counteract trichostatin A-induced esophageal cancer progression. World J Gastroenterol. 2025;31(20):106443.","journal-title":"World J Gastroenterol"},{"key":"4323_CR53","doi-asserted-by":"publisher","DOI":"10.20517\/2394-4722.2023.134","author":"N Mcbrearty","year":"2024","unstructured":"Mcbrearty N, Bahal D, Platero S. Fast-tracking drug development with biomarkers and companion diagnostics. Cancer Metastasis Treat. 2024. https:\/\/doi.org\/10.20517\/2394-4722.2023.134.","journal-title":"Cancer Metastasis Treat"},{"issue":"3","key":"4323_CR54","first-page":"105","volume":"10","author":"RM Joshi","year":"2024","unstructured":"Joshi RM, Telang B, Soni G, Khalife A. Overview of perspectives on cancer,newer therapies,and future directions. Oncol Translational Med. 2024;10(3):105\u20139.","journal-title":"Oncol Translational Med"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-04323-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-04323-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-04323-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T12:03:13Z","timestamp":1770724993000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-04323-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,14]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4323"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-04323-z","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,14]]},"assertion":[{"value":"16 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the ethics committee of the Affiliated Zhuzhou Hospital Xiangya Medical College CSU (No. 2020154-01). All methods involving human participants were carried out in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. All the animal experiments were approved by the Animal Ethics Committee of the Second Xiangya Hospital, Central South University (No. 2020398) and were conducted in accordance with relevant institutional guidelines and local regulations.\u00a0All patients signed an informed consent form.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors reviewed and approved the final manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"275"}}